PheCheck™ Validation Study
Purpose
The goal of this observational study is to evaluate the performance of the PheCheck™ test for the rapid detection of phenylalanine (Phe) from a fingerstick sample, in patients 1 year or older with phenylketonuria (PKU) or hyperphenylalaninemia. The main objective is comparing the concentration of phenylalanine (Phe) in capillary blood with the reference method (DBS).
Condition
- Phenylketonuria (PKU) and Hyperphenylalaninemia
Eligibility
- Eligible Ages
- Over 1 Year
- Eligible Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- 1 year or older and able to have a fingerstick blood collected - Being monitored for Phenylketonuria (classical PKU, mild PKU, variant PKU, or hyperphenylalaninemia) - Signed informed consent
Exclusion Criteria
- Previous enrollment in the study and has completed 3 study visits - Inability to read and understand instructions
Study Design
- Phase
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Arm Groups
| Arm | Description | Assigned Intervention |
|---|---|---|
| Patients with Phenylketonuria or Hyperphenylalaninemia | Device: PheCheck Test Description: Quantitative, single-use, rapid test Intended for home-based self-testing and monitoring of PKU. 1 fingerstick specimen collected at each study visit Comparator: Dried Blood Spot Cards. 1 fingerstick specimen collected at each study visit |
|
Recruiting Locations
Chicago, Illinois 60611
More Details
- Status
- Recruiting
- Sponsor
- Aptatek BioSciences, Inc
Detailed Description
The primary objective of this study is to evaluate the performance of the PheCheck™ test for the rapid, quantitative detection of phenylalanine (Phe) direct from a capillary (fingerstick) sample. Results will be compared to reference testing from Dried Blood Spot Cards (DBS). The PheCheck™ test performs a quantitative determination of phenylalanine in a self-collected or parent/guardian-collected capillary blood sample. The analysis will evaluate the performance of the analyte concentration of phenylalanine in prospectively collected samples self-collected and tested by patients with PKU, measured by the PheCheck™ test as compared to the standard of care DBS testing performed by a reference lab